CoChat

Reduction of the false-positive rate in newborn screening by implementation of MS/MS-based second-tier tests: the Mayo Clinic experience (2004–2007)

Matern, D., Tortorelli, S., Oglesbee, D., Gavrilov, D., Rinaldo, P. · 2007 · Journal of Inherited Metabolic Disease

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

The continued expansion of newborn screening programmes to include additional conditions increases the responsibility of newborn screening laboratories to provide testing with the highest sensitivity and specificity to allow for identification of affected patients while minimizing the false-positive rate. Some assays and analytes are particularly problematic. Over recent years, our laboratory tried to improve this situation by developing second-tier tests to reduce false-positive results in the screening for congenital adrenal hyperplasia (CAH), tyrosinaemia type I, methylmalonic acidaemias, homocystinuria, and maple syrup urine disease (MSUD). Beginning in 2004, this approach was applied to Mayo's newborn screening programme and resulted in a false-positive rate of 0.09%, a positive predictive value of 41%, and a positive detection rate of 1 affected case in 1672 babies screened.

Overview

Integrity signals

Registry

Crossref · 10.1007/s10545-007-0691-y

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 30 references

Research works printed but not linked: 3

  1. Kirk K, 2007, Paper presented at 2007 Newborn Screening and Genetic Testing Symposium
  2. Matern D, 2005, Paper presented at 2005 Newborn Screening and Genetic Testing Symposium
  3. Saavedra‐Matiz C, 2007, Paper presented at 2007 Newborn Screening and Genetic Testing Symposium

Cited by

See all 231

Metadata

Authors
Matern, D., Tortorelli, S., Oglesbee, D., Gavrilov, D., & Rinaldo, P.
Affiliations
Mayo Clinic (US)
Corresponding author
Matern, D.
Venue
Journal of Inherited Metabolic Disease
Publisher
Wiley
Published
2007-07-23
Volume
30
Issue
4
Pages
585-592
ISSN
  • 0141-8955 (ISSN-L)
  • 1573-2665
OpenAlex
W1981566444
Cited by
217
References
30
Citations by year
2026: 3 · 2025: 8 · 2024: 7 · 2023: 13 · 2022: 14 · 2021: 24 · 2020: 15 · 2019: 9 · 2018: 9 · 2017: 9 · 2016: 6 · 2015: 10 · 2014: 13 · 2013: 9 · 2012: 10
FWCI
8.11
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Inherited Metabolic Disease (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
Keywords
newborn screening, false positive rate, second-tier testing, tandem mass spectrometry, congenital adrenal hyperplasia, methylmalonic acidemia, homocystinuria, maple syrup urine disease, positive predictive value, inborn errors of metabolism
MeSH terms
Adrenal Hyperplasia, Congenital, False Positive Reactions, Homocystinuria, Humans, Infant, Newborn, Maple Syrup Urine Disease, Predictive Value of Tests, Sensitivity and Specificity, Mass Spectrometry, Time Factors, Vitamin B 12 Deficiency, Neonatal Screening, Tyrosinemias

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reduction of the false-positive rate in newborn screening by implementation of MS/MS-based second-tier tests: the Mayo Clinic experience (2004–2007). https://app.cochat.ai/papers/10.1007/s10545-007-0691-y
The paper
Matern, D., Tortorelli, S., Oglesbee, D., Gavrilov, D., & Rinaldo, P. (2007). Reduction of the false-positive rate in newborn screening by implementation of MS/MS-based second-tier tests: the Mayo Clinic experience (2004–2007). Journal of Inherited Metabolic Disease. https://doi.org/10.1007/s10545-007-0691-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.